Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6152049rdf:typepubmed:Citationlld:pubmed
pubmed-article:6152049lifeskim:mentionsumls-concept:C0014780lld:lifeskim
pubmed-article:6152049lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:6152049lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6152049pubmed:issue4lld:pubmed
pubmed-article:6152049pubmed:dateCreated1985-3-26lld:pubmed
pubmed-article:6152049pubmed:abstractTextThe effect of two nitroimidazoles, 1(2'-hydroxy-3'-chloropropyl)-2-methyl-4-nitroimidazol and 1(2'-hydroxy-3'-chloropropyl)-2-methyl-5-nitroimidazol and irradiation on erythrocyte membrane ATP-ase activity was studied. The action of nitroimidazole derivatives on the erythrocyte membrane ATP-ase activity differed depending on the nitro group position. 5-Nitroimidazole derivative in the concentration of 300 micrograms/mg protein inhibited significantly the non-irradiated erythrocyte membrane (Na+, K+) ATP-ase activity, while 4-NO2 in the concentration of 3 micrograms/mg protein influenced this activity, but only after an exposure at dose of 60 Krad. In the concentration of 300 micrograms/mg membrane protein it activated this ATP-ase.lld:pubmed
pubmed-article:6152049pubmed:languageenglld:pubmed
pubmed-article:6152049pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152049pubmed:citationSubsetIMlld:pubmed
pubmed-article:6152049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152049pubmed:statusMEDLINElld:pubmed
pubmed-article:6152049pubmed:issn0301-0244lld:pubmed
pubmed-article:6152049pubmed:authorpubmed-author:ChmielJJlld:pubmed
pubmed-article:6152049pubmed:authorpubmed-author:Rybczy?skaMMlld:pubmed
pubmed-article:6152049pubmed:authorpubmed-author:PhilippWWlld:pubmed
pubmed-article:6152049pubmed:issnTypePrintlld:pubmed
pubmed-article:6152049pubmed:volume36lld:pubmed
pubmed-article:6152049pubmed:ownerNLMlld:pubmed
pubmed-article:6152049pubmed:authorsCompleteYlld:pubmed
pubmed-article:6152049pubmed:pagination307-12lld:pubmed
pubmed-article:6152049pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6152049pubmed:meshHeadingpubmed-meshheading:6152049-...lld:pubmed
pubmed-article:6152049pubmed:meshHeadingpubmed-meshheading:6152049-...lld:pubmed
pubmed-article:6152049pubmed:meshHeadingpubmed-meshheading:6152049-...lld:pubmed
pubmed-article:6152049pubmed:meshHeadingpubmed-meshheading:6152049-...lld:pubmed
pubmed-article:6152049pubmed:meshHeadingpubmed-meshheading:6152049-...lld:pubmed
pubmed-article:6152049pubmed:meshHeadingpubmed-meshheading:6152049-...lld:pubmed
pubmed-article:6152049pubmed:meshHeadingpubmed-meshheading:6152049-...lld:pubmed
pubmed-article:6152049pubmed:meshHeadingpubmed-meshheading:6152049-...lld:pubmed
pubmed-article:6152049pubmed:articleTitleEffects of nitroheterocyclic sensitizers on erythrocyte membranes ATP-ase activity.lld:pubmed
pubmed-article:6152049pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6152049pubmed:publicationTypeIn Vitrolld:pubmed